In this context, the count of hybrid CTCs and the expression of MMP2 in these types of CTCs may play a significant role, which could be of great importance for guiding the treatment and monitoring disease progression in nasopharyngeal cancer. The gene discussed is MMP2; the disease is nasopharyngeal carcinoma.